Literature DB >> 31676058

Genetic and Environmental Considerations for Inflammatory Bowel Disease.

Angela Kuhnen1.   

Abstract

Inflammatory bowel disease is a chronic inflammatory disorder of the gastrointestinal tract driven by an exaggerated immune response to luminal microbiota in susceptible individuals. It presents with a heterogenous pattern of clinical disease severity, location, and behavior. Understanding the interaction between the host genome, gut microbiome, and further environmental exposures in the development of IBD is in the early stages, and factors that trigger onset of disease in susceptible individuals remain unknown. This article addresses the genetic, microbial, and environmental influences on development of inflammatory bowel disease and the ability to manipulate these factors through surgery and medical therapy.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Crohn's disease; Fecal microbial transplantation; Gut microbiome; Heritability; Ileal pouch–anal anastomosis; Inflammatory bowel disease; Pouchitis; Ulcerative colitis

Mesh:

Year:  2019        PMID: 31676058     DOI: 10.1016/j.suc.2019.08.014

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  9 in total

1.  Suppression of Inflammatory Cytokines Expression with Bitter Melon (Momordica Charantia) in TNBS-instigated Ulcerative Colitis.

Authors:  Asli Semiz; Ozden Ozgun Acar; Hulya Cetin; Gurkan Semiz; Alaattin Sen
Journal:  J Transl Int Med       Date:  2020-09-25

Review 2.  Probiotics Interact With Lipids Metabolism and Affect Gut Health.

Authors:  Taoying Wu; Guangqiang Wang; Zhiqiang Xiong; Yongjun Xia; Xin Song; Hui Zhang; Yan Wu; Lianzhong Ai
Journal:  Front Nutr       Date:  2022-05-31

3.  Whole Transcription Profile of Responders to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease.

Authors:  Sara Salvador-Martín; Bartosz Kaczmarczyk; Rebeca Álvarez; Víctor Manuel Navas-López; Carmen Gallego-Fernández; Ana Moreno-Álvarez; Alfonso Solar-Boga; Cesar Sánchez; Mar Tolin; Marta Velasco; Rosana Muñoz-Codoceo; Alejandro Rodriguez-Martinez; Concepción A Vayo; Ferrán Bossacoma; Gemma Pujol-Muncunill; María J Fobelo; Antonio Millán-Jiménez; Lorena Magallares; Eva Martínez-Ojinaga; Inés Loverdos; Francisco J Eizaguirre; José A Blanca-García; Susana Clemente; Ruth García-Romero; Vicente Merino-Bohórquez; Rafael González de Caldas; Enrique Vázquez; Ana Dopazo; María Sanjurjo-Sáez; Luis A López-Fernández
Journal:  Pharmaceutics       Date:  2021-01-08       Impact factor: 6.321

4.  Assessment of patients' understanding of inflammatory bowel diseases: Development and validation of a questionnaire.

Authors:  Gaiana Ostromohov; Morin Fibelman; Ayal Hirsch; Yulia Ron; Nathaniel Aviv Cohen; Revital Kariv; Liat Deutsch; Jasmine Kornblum; Ronit Anbar; Nitsan Maharshak; Naomi Fliss-Isakov
Journal:  United European Gastroenterol J       Date:  2021-12-23       Impact factor: 4.623

5.  Exploration of Potential Gut Microbiota-Derived Biomarkers to Predict the Success of Fecal Microbiota Transplantation in Ulcerative Colitis: A Prospective Cohort in Korea.

Authors:  Gi-Ung Kang; Sowon Park; Yeongyun Jung; Jai J Jee; Min-Sueng Kim; Seungjun Lee; Dong-Woo Lee; Jae-Ho Shin; Hong Koh
Journal:  Gut Liver       Date:  2022-08-17       Impact factor: 4.321

Review 6.  Sexual Dysfunction in Inflammatory Bowel Disease: What the Specialist Should Know and Ask.

Authors:  Edith Perez de Arce; Rodrigo Quera; Jaqueline Ribeiro Barros; Ligia Yukie Sassaki
Journal:  Int J Gen Med       Date:  2021-05-24

7.  Polyphenolic Maqui Extract as a Potential Nutraceutical to Treat TNBS-Induced Crohn's Disease by the Regulation of Antioxidant and Anti-Inflammatory Pathways.

Authors:  Tamara Ortiz; Federico Argüelles-Arias; Matilde Illanes; Josefa-María García-Montes; Elena Talero; Laura Macías-García; Ana Alcudia; Victoria Vázquez-Román; Virginia Motilva; Manuel De-Miguel
Journal:  Nutrients       Date:  2020-06-11       Impact factor: 5.717

8.  Gene Signatures of Early Response to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease.

Authors:  Sara Salvador-Martín; Irene Raposo-Gutiérrez; Víctor Manuel Navas-López; Carmen Gallego-Fernández; Ana Moreno-Álvarez; Alfonso Solar-Boga; Rosana Muñoz-Codoceo; Lorena Magallares; Eva Martínez-Ojinaga; María J Fobelo; Antonio Millán-Jiménez; Alejandro Rodriguez-Martinez; Concepción A Vayo; Cesar Sánchez; Mar Tolin; Ferrán Bossacoma; Gemma Pujol-Muncunill; Rafael González de Caldas; Inés Loverdos; José A Blanca-García; Oscar Segarra; Francisco J Eizaguirre; Ruth García-Romero; Vicente Merino-Bohórquez; María Sanjurjo-Sáez; Luis A López-Fernández
Journal:  Int J Mol Sci       Date:  2020-05-09       Impact factor: 5.923

9.  Interoceptive Abilities in Inflammatory Bowel Diseases and Irritable Bowel Syndrome.

Authors:  Alicia Fournier; Laurie Mondillon; Olivier Luminet; Fréderic Canini; Nicolas Mathieu; Anne Sophie Gauchez; Cécile Dantzer; Bruno Bonaz; Sonia Pellissier
Journal:  Front Psychiatry       Date:  2020-04-02       Impact factor: 4.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.